Učitavanje...
Prolonged survival with longer duration of maintenance lenalidomide after autologous hematopoietic stem cell transplantation for multiple myeloma
BACKGROUND: Though lenalidomide maintenance therapy has demonstrated improved outcomes after autologous hematopoietic stem cell transplantation (auto-HCT) in patients with multiple myeloma (MM), the impact of the duration of this therapy is not clearly known. PATIENTS AND METHODS: We retrospectively...
Spremljeno u:
| Izdano u: | Cancer |
|---|---|
| Glavni autori: | , , , , , , , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2016
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5138119/ https://ncbi.nlm.nih.gov/pubmed/27680710 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.30366 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|